Imo-2055

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

Imo-2055 is an investigational medication currently being studied in clinical trials for colorectal cancer. It is not yet approved for use in patients. The drug is being tested in combination with standard chemotherapy regimens like FOLFIRI (which includes irinotecan and leucovorin) and cetuximab. Clinical trials, specifically Phase 1 studies, are designed to determine the safest dose of Imo-2055 and how well it can be tolerated when given with these other treatments. The goal is to see if adding Imo-2055 to existing therapies can improve outcomes for people with colorectal cancer. The trials are evaluating the safety and tolerability of Imo-2055 in combination with FOLFIRI and cetuximab.

Mechanism of Action

Imo-2055 is being investigated as a potential treatment for colorectal cancer. The specific way it works (its mechanism of action) is still being studied. It is being tested in combination with standard chemotherapy (FOLFIRI) and a targeted therapy (cetuximab) to see if it can enhance their effects or offer additional benefits. The trials are exploring how Imo-2055 interacts with these other drugs and its potential impact on tumor cells.

Side Effects

As Imo-2055 is an investigational drug in early-phase clinical trials (Phase 1) The full range of potential side effects is still being evaluated. The primary focus of these early trials is to assess safety and determine the maximum tolerated dose when combined with other treatments like FOLFIRI and cetuximab. Common side effects associated with FOLFIRI (like diarrhea Nausea Fatigue) and cetuximab (like rash Diarrhea) are expected and will be closely monitored. Specific side effects related to Imo-2055 itself are still being characterized in ongoing trials.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT00719199 Phase 1
Archived
Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer
United States

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
781 trials
Leucovorin
Other Medications
641 trials
Paclitaxel
Other Medications
54 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials
Trifluridine
Other Medications
48 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.